Shanghai perhum therapeutics
WebbShanghai PerHum Therapeutics ("PerHum") was formed in 2016 for the express purpose of developing novel CAB-CAR-T therapies for solid tumor malignancies in China. Contact Who is Shanghai PerHum Therapeutics Headquarters Shanghai, Shanghai, China Phone Number +86 2134512787 Website www.perhum.com Revenue <$5M Industry Business … Webb12 sep. 2024 · There are two main strategies to develop drugs targeting Axl-GAS6. One is to directly inhibit Axl, and the other is to inhibit GAS6 to prevent its binding to Axl, i.e., ligand capture. These drugs are suitable for tumor drug resistance therapy or …
Shanghai perhum therapeutics
Did you know?
WebbShanghai PerHum Therapeutics Co. Ltd. Headquarters: Shanghai, China Website: http://www.perhum.com Year Founded: 2016 Status: Private BioCentury Dec 21, 2024 … Webb21 maj 2024 · MAINZ, Germany--(BUSINESS WIRE)-- EXUMA Biotechnology and affiliate Shanghai PerHum Therapeutics announced today interim results of two first-in-human …
Webb22 maj 2024 · Shanghai PerHum Therapeutics Co., Ltd. Study Details Tabular View No Results Posted Disclaimer How to Read a Study Record Study Description Go to Brief … Webb10 aug. 2024 · Shanghai PerHum Therapeutics Co., Ltd. Collaborator Shanghai Zhongshan Hospital Provider of Information About this Clinical Study Sponsor Conditions in This Trial Solid Tumor Gastric Cancer Breast Cancer Ovarian Cancer Sarcoma Additional Key Areas Provided by Investigators HER2 CAR-T Solid tumors Interventions in This Trial CCT303-406
WebbDeveloper EXUMA Biotech; Fudan University Zhongshan Hospital; Shanghai PerHum Therapeutics; Shanghai Sinobioway Sunterra Biotechnology Class CAR-T cell therapies; … Webb10 nov. 2024 · Shanghai PerHum Therapeutics Co., Ltd. Collaborator. Shanghai Zhongshan Hospital; Provider of Information About this Clinical Study Sponsor; Overall Contact(s) Yuhong Zhou, M.D., +86-21-64041990, [email protected]; Conditions in This Trial. SAR; Additional Key Areas Provided by Investigators.
WebbShanghai PerHum Therapeutics ("PerHum") was formed in 2016 for the express purpose of developing novel CAB-CAR-T therapies for solid tumor malignancies in China. Contact …
WebbFor the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports … hightablecorpWebb22 mars 2024 · For HER2 Positive Breast Cancer Emerging drugs, the HER2 Positive Breast Cancer pipeline analysis report provides a 360° view of the therapeutics landscape by development point, product type ... hight water markWebb2 Shanghai PerHum Therapeutics Co. Ltd., Shanghai 200052, P.R. China. PMID: 32323752 DOI: 10.3892/ijmm.2024.4527 Abstract The expression of anillin mRNA and protein is regulated in a cell cycle‑dependent manner. However, the mechanism underlying ... hightae floodingWebbPerhum therapeutics has developed a modified chimeric antigen receptor ... Shanghai Pu'er Biotechnology Overview. Founded Year 2016. Location Shanghai, China. Company Stage Funding Raised. Similar Cos. Ginkgo Bioworks, Human Longevity, Amyris, Bionano Genomics, Relay Therapeutics & 3271 others. small shoe storage seatWebb10 nov. 2024 · May 5, 2024 updated by: Shanghai PerHum Therapeutics Co., Ltd. A Phase I Trial to Assess Safety, Tolerability and Anti-tumor Activity of Autologous T Cell Modified Chimeric Antigen Receptor (CAR) (CCT301-38) in Patients With Relapsed or Refractory AXL Positive Sarcomas. small shoe stretcherWebb21 maj 2024 · MAINZ, Germany, May 21, 2024 — EXUMA Biotechnology and affiliate Shanghai PerHum Therapeutics announced today interim results of two first-in-human … small shoe storage unitsWebb23 maj 2024 · - German biotechnology company Exuma biotechnology and affiliate Shanghai PerHum Therapeutics have presented interim results of two first-in-human … hightae houses for sale